Oct 7, 2026Journal ArticleWhen Programs Vanish: The Unseen Consequences.Written by 1 Roon author Via Clinical Infectious Diseases
Feb 4, 2026Journal ArticleShort Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.Written by 2 Roon authors & 18 others Via Clinical Infectious Diseases
ResearchLessons Learned from Viral Hepatitis Testing That Inform Law and Policy Responses to Steatotic Liver Disease
ResearchEvaluating Spatially Targeted HIV Interventions and Harm Reduction Services Among People Who Inject Drugs in a High-Burden Setting
ResearchWhat, How, and When Matters: Acceptability and Preferences for HIV Pre-Exposure Prophylaxis Among People Who Inject Drugs in New Delhi, India
ResearchAcceptability and Preferences of Long-Acting Injectable Pre-Exposure Prophylaxis and Antiretroviral Therapy Among Men Who Have Sex With Men and People Who Inject Drugs in India
ResearchGeometric Deep Learning Enables High-Fidelity Network Imputation for HIV Transmission Modeling
ResearchHIV Testing Service Utilization Among Transgender Communities: Insights from a Respondent-Driven Sampling Survey in India
ResearchIncreasing Syphilis Prevalence Among MSM Across India Despite Improvements in the HIV Care Continuum
ResearchA Precision Randomized Trial of Hepatitis C Treatment Support Among People Who Inject Drugs in India: The STOP-C Trial
ResearchEfficiency of Respondent-Driven Sampling for Identifying Men Who Inject Drugs Living with HIV and/or Hepatitis C over Time in Varanasi, India
ResearchPiloting an Event-Based Surveillance Model in Private Hospitals for Early Detection of Disease Clusters, Kerala, India
ResearchSocial Support and HIV Management Among People Who Inject Drugs: In-Depth Interviews in Delhi, India
ResearchPeople Who Inject Drugs and Men Who Have Sex With Men Living with HIV in India Experience Low Probability of Viral Rebound and High Levels of Persistent Viremia During the First 12 Months of Antiretroviral Therapy